BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 18061920)

  • 1. Medicinal chemistry aspects of drug targets in sphingolipid metabolism.
    Nussbaumer P
    ChemMedChem; 2008 Apr; 3(4):543-51. PubMed ID: 18061920
    [No Abstract]   [Full Text] [Related]  

  • 2. Sphingolipid metabolizing enzymes as novel therapeutic targets.
    Billich A; Baumruker T
    Subcell Biochem; 2008; 49():487-522. PubMed ID: 18751924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel chemotherapeutic drugs in sphingolipid cancer research.
    Canals D; Hannun YA
    Handb Exp Pharmacol; 2013; (215):211-38. PubMed ID: 23579458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitors of sphingolipid metabolism enzymes.
    Delgado A; Casas J; Llebaria A; Abad JL; Fabrias G
    Biochim Biophys Acta; 2006 Dec; 1758(12):1957-77. PubMed ID: 17049336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitors of sphingosine-1-phosphate metabolism (sphingosine kinases and sphingosine-1-phosphate lyase).
    Sanllehí P; Abad JL; Casas J; Delgado A
    Chem Phys Lipids; 2016 May; 197():69-81. PubMed ID: 26200919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug targeting of sphingolipid metabolism: sphingomyelinases and ceramidases.
    Canals D; Perry DM; Jenkins RW; Hannun YA
    Br J Pharmacol; 2011 Jun; 163(4):694-712. PubMed ID: 21615386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sphingolipid modulation: a strategy for cancer therapy.
    Delgado A; Fabrias G; Bedia C; Casas J; Abad JL
    Anticancer Agents Med Chem; 2012 May; 12(4):285-302. PubMed ID: 21864240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic disorders of simple sphingolipid metabolism.
    Albinet V; Bats ML; Bedia C; Sabourdy F; Garcia V; Ségui B; Andrieu-Abadie N; Hornemann T; Levade T
    Handb Exp Pharmacol; 2013; (215):127-52. PubMed ID: 23579453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sphingolipids and response to chemotherapy.
    Dimanche-Boitrel MT; Rebillard A
    Handb Exp Pharmacol; 2013; (216):73-91. PubMed ID: 23563652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sphingolipid metabolism in the regulation of bioactive molecules.
    Luberto C; Hannun YA
    Lipids; 1999; 34 Suppl():S5-11. PubMed ID: 10419081
    [No Abstract]   [Full Text] [Related]  

  • 11. Novel drugs targeting sphingolipid metabolism.
    Bhabak KP; Arenz C
    Handb Exp Pharmacol; 2013; (215):187-96. PubMed ID: 23579456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sphingolipid hydrolyzing enzymes in the gastrointestinal tract.
    Duan RD; Nilsson A
    Methods Enzymol; 2000; 311():276-86. PubMed ID: 10563333
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of yeast as a model system for studies of sphingolipid metabolism and signaling.
    Chung N; Obeid LM
    Methods Enzymol; 2000; 311():319-31. PubMed ID: 10563337
    [No Abstract]   [Full Text] [Related]  

  • 14. [Transcriptional regulation of sphingolipid metabolic enzymes].
    Murate T
    Seikagaku; 2007 Dec; 79(12):1139-43. PubMed ID: 18203454
    [No Abstract]   [Full Text] [Related]  

  • 15. Enzymes of sphingolipid metabolism in Drosophila melanogaster.
    Acharya U; Acharya JK
    Cell Mol Life Sci; 2005 Jan; 62(2):128-42. PubMed ID: 15666085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ceramide synthase inhibition by fumonisin B1 treatment activates sphingolipid-metabolizing systems in mouse liver.
    He Q; Suzuki H; Sharma N; Sharma RP
    Toxicol Sci; 2006 Dec; 94(2):388-97. PubMed ID: 16960033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sphingolipids in the lungs.
    Uhlig S; Gulbins E
    Am J Respir Crit Care Med; 2008 Dec; 178(11):1100-14. PubMed ID: 18755926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of ceramide and sphingolipid metabolism in tumors: potential modulation of chemotherapy.
    Modrak DE
    Methods Mol Med; 2005; 111():183-94. PubMed ID: 15911980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sphingolipid signaling in metabolic disorders.
    Hla T; Dannenberg AJ
    Cell Metab; 2012 Oct; 16(4):420-34. PubMed ID: 22982021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of high-fat diet on the sphingolipid pathway of signal transduction in regenerating rat liver.
    Zabielski P; Baranowski M; Błachnio-Zabielska A; Zendzian-Piotrowska M; Górski J
    Prostaglandins Other Lipid Mediat; 2010 Nov; 93(3-4):75-83. PubMed ID: 20599517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.